LLMpediaThe first transparent, open encyclopedia generated by LLMs

ribosome

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Molecular biology Hop 4
Expansion Funnel Raw 77 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted77
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()

ribosome. A complex molecular machine found in all cells, it is the site of biological protein synthesis, translating genetic information into functional chains of amino acids. Composed of ribonucleic acid and proteins, it facilitates the precise assembly of proteins essential for cellular life. Its discovery and study have been fundamental to modern biology and therapeutic development.

Structure and composition

The universal architecture consists of two subunits of differing sizes that assemble only during protein synthesis. In prokaryotic organisms like E. coli, the subunits are designated 30S and 50S, forming a complete 70S particle. In eukaryotes such as humans, the subunits are larger, termed 40S and 60S, combining into an 80S complex. Each subunit is a intricate assembly of rRNA molecules and dozens of distinct ribosomal proteins, with the rRNA forming the core catalytic framework. Key structural features include the aminoacyl, peptidyl, and exit sites for tRNA binding, the peptidyl transferase center primarily composed of rRNA, and the mRNA channel. Structural biology techniques like X-ray crystallography and cryo-EM, pioneered by researchers including Ada Yonath, Venkatraman Ramakrishnan, and Thomas Steitz, have revealed these details at atomic resolution.

Function in protein synthesis

The primary role is to catalyze the process of translation, decoding the sequence of messenger RNA to produce a specific polypeptide chain. The cycle involves three main stages: initiation, where the small subunit binds the mRNA near the start codon with initiation factors like eIF4E; elongation, a repetitive cycle of tRNA binding, peptide bond formation catalyzed by the rRNA, and translocation driven by proteins like EF-G; and termination, when a stop codon is recognized by release factors such as RF1 in E. coli, prompting the release of the completed protein. The process requires coordinated action with numerous translation factors and consumes GTP for energy.

Ribosome biogenesis

The assembly of new particles is a highly energy-intensive and complex process involving the nucleolus in eukaryotic cells. It requires the transcription of rDNA by RNA polymerase I and III, extensive processing of the precursor rRNA transcripts by complexes like the snoRNP machinery, and the import and ordered assembly of ribosomal proteins synthesized in the cytoplasm. In bacteria, this occurs in the cytosol, but in eukaryotes, it involves export of the subunits from the nucleus through the nuclear pore complex. This pathway is tightly regulated by signaling networks including the mTOR pathway and is surveilled by quality control mechanisms; its dysregulation is linked to diseases like Diamond-Blackfan anemia.

Evolution and diversity

These particles are ancient and highly conserved, with their rRNA sequence serving as a cornerstone for phylogenetic studies and the construction of the tree of life by Carl Woese. The rRNA core of the peptidyl transferase center is considered a molecular fossil from the RNA world hypothesis. While the core function is universal, structural variations exist, such as the unique features of mitochondrial and chloroplast ribosomes, which reflect their endosymbiotic origins. The archaeal ribosome shares more features with the eukaryotic than the bacterial version, providing evidence for evolutionary relationships. Extremophiles like those in the genus *Thermus* possess particles stabilized for function in extreme environments.

Ribosomes in medicine and biotechnology

They are major targets for antibiotics, which exploit structural differences between prokaryotic and eukaryotic versions to achieve selective toxicity. Classic inhibitors include aminoglycosides like streptomycin, tetracyclines, and macrolides such as erythromycin, which bind to specific sites on the bacterial ribosome to disrupt translation. Understanding these interactions, elucidated through structural work by teams at the MRC Laboratory, informs the design of new drugs to combat antimicrobial resistance. In biotechnology, engineered versions are used for specialized protein production, including the incorporation of non-canonical amino acids for research and therapeutic purposes, a technology advanced by institutions like Scripps Research.

Category:Molecular biology Category:Cell biology Category:Non-membrane-bound organelles